No two bodies respond the same way. What works for one may fail for another. Dr Majhi advises, “Understanding your body’s unique metabolic needs and addressing underlying issues is key.” This is where medical evaluation becomes important. Blood tests, hormone checks, and metabolic assessments can reveal what diet alone cannot. The same applies to weight. … Read more
Semaglutide, a common ingredient in GLP-1 weight-loss medications, is associated with lower risks of worsening mental disorders, according to a new study. ADVERTISEMENT ADVERTISEMENT The research, published in The Lancet Psychiatry, found that people following a GLP-1 treatment for diabetes and obesity had a lower need for hospital care and medical leave due to psychiatric … Read more
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while preserving muscle function and easing fears about harmful muscle wasting. Key takeaways Fat, not skeletal muscle, accounted for most of the weight loss. According to the study, GLP-1 medicines reduced body fat in obese mice much more … Read more
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing Type 2 diabetes, according to preliminary research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026. The meeting is in Boston, March 17-20, 2026, and offers the latest science … Read more
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or try alternative therapies, helping explain why average weight regain after discontinuation may be smaller than expected. Study: Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide. Image credit: KaterynaBorodina/Shutterstock.com Obesity treatment has … Read more
Yo-yos are inexpensive kids’ toys that seem to defy gravity. But when the yo-yo’s movement describes how many people gain weight and then lose weight and then gain again, it’s no fun. Constantly gaining and losing weight, known to the public as “yo-yo” dieting, remains harmful. However, researchers at Ben-Gurion University of the Negev (BGU) … Read more
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful weight loss while simultaneously protecting the heart, kidneys, and metabolic health. Review: GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits. Image Credit: Gecko Studio / Shutterstock In a recent review published in The … Read more
A mother-of-two who was comfort eating for “almost 24 hours” a day, reaching her heaviest weight of 95kg (14st 13lbs), has lost nearly half her body weight and started a modelling career in her 40s. Lenne De Gerbolli, 47, who lives in London, had always been petite and athletic but said this all changed when … Read more
The mother-of-two to Penny, nine, and Megan, 15, said she had no self-esteem and would avoid going outside – she has now shed an impressive six stone and feels great Molly Powell PA and rsvp Administrator 16:07, 01 Mar 2026 Carly is now more confident than ever(Image: Collect/PA Real Life) A healthcare assistant who lost … Read more
Obesity is now one of the world’s biggest health challenges. Nearly 900 million adults worldwide are living with obesity, driving up rates of diabetes, heart disease, and certain cancers. Traditional weight‑loss methods often don’t deliver lasting results, so researchers are searching for new answers. One promising option is GLP‑1 drugs, which help people lose weight … Read more